Crossmark

HLA genetic polymorphisms and prognosis of patients with COVID-19

Crossref DOI link: https://doi.org/10.1016/j.medin.2020.08.004

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lorente, L.

Martín, M.M.

Franco, A.

Barrios, Y.

Cáceres, J.J.

Solé-Violán, J.

Perez, A.

Marcos y Ramos, J.A.

Ramos-Gómez, L.

Ojeda, N.

Jiménez, A.

Lorente, Leonardo

Franco, Andrés

Barrios, Yvelise

Perez, Alina

Jiménez, Alejandro

Pérez-Cejas, Antonia

Pérez-Llombet, Alejandra

Uribe, Luis

González, Lourdes

Alvarez, Rocío

Martín, María M.

Alcoba-Flórez, Julia

Estupiñan, Albano

Cáceres, Juan J.

Vega, Paula

Gonzalez, Lucía

Solé-Violán, Jordi

Ojeda, Nazario

López, Sergio

Rodríguez-Pérez, Aurelio

Domínguez, Casimira

Marcos y Ramos, José Alberto

Zapata, María F.

Ramos-Gómez, Luis

Ortiz-López, Raquel
Funding

Funding for this research was provided by:

European Regional Development Fund (PI-18-00500)

Instituto de Salud Carlos III (PI-18-00500)
License Information

Text and Data Mining valid from 2021-03-01
More Information

This article is maintained by: Elsevier

Article Title: HLA genetic polymorphisms and prognosis of patients with COVID-19

Journal Title: Medicina Intensiva

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medin.2020.08.004

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.